Mar 17, 2020
Sickle Cell Anemia Industry Outlook to 2026 Featuring CRISPR Therapeutics, Global Blood Therapeutics, Novartis, Pfizer, and Vertex Pharmaceuticals
Nov 27, 2019
The Erythropoietin Stimulating Agents Market in Latin America (2019-2027): Data on Epoetin-Alfa, Epoetin-Beta, Epoetin-Theta, Darbepoetin-Alfa, and Other ESAs
Nov 06, 2019
Sierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
Oct 29, 2019
Disc Medicine Expands Pipeline Focused on Hepcidin Pathway
Oct 24, 2019
Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells
Oct 18, 2019
Global Fanconi Anemia (FA) Pipeline Insights 2019 - Treatment Patterns, Analytical Perspective, Pipeline Therapeutics, Products Analysis, Recent Technologies, Key Companies
Oct 03, 2019
Hemanext to Present Extensive, Significant Red Blood Cell Data at AABB 2019
Jul 12, 2019
Trivedi Global, Inc. Announces Research by Alice Branton on Energy Treated Iron to Potentiall Provide a Better Therapeutic Response to Anmenia
Jun 19, 2019
On World Sickle Cell Day, Medunik USA highlights the importance of early treatment of Sickle Cell Disease
Apr 18, 2019
Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature
Apr 09, 2019
Medunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus
Mar 04, 2019
Important New Trial With Oral FERACCRU® Shows Comparable Efficacy to IV Iron (Ferric Carboxymaltose), Offering a Real Alternative to Hospital Administration for Many Patients[4]
Feb 21, 2019
Dosis Expands Use of AI-Powered Strategic Anemia Advisor to 50 Dialysis Clinics
Feb 20, 2019
HemoCue Announces FDA 510(k) Clearance and U.S. Launch of Its Latest Point-of-Care Hemoglobin Test, the HemoCue® Hb 801 System
Feb 13, 2019
Renal Anemia Treatment Market Will Reach at a CAGR of 7.5% Through 2026: Persistence Market Research
Jan 14, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat(TM) for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital
Jan 09, 2019
Protagonist Therapeutics Initiates Phase 2 Trial of Novel Hepcidin Mimetic PTG-300 for the Treatment of Patients with Beta Thalassemia
Dec 17, 2018
Sutimlimab Shows Promise for Hard-to-Treat, Rare Blood Disorder
Dec 01, 2018
Sickle Cell Anemia Treatment Safely Lowers Disease Burden in African Children
Nov 19, 2018
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing